Melissa Layman

Insider Reports History

Location
Burlington, MA
Signature
/s/ Mark S. Levine, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Melissa Layman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Flexion Therapeutics Inc Chief Commercial Officer Common Stock 0 $8.50 19 Nov 2021 Direct
Flexion Therapeutics Inc Chief Commercial Officer Performance Restricted Stock Unit Award 0 19 Nov 2021 Direct
Flexion Therapeutics Inc Chief Commercial Officer Stock Option (right to buy) 0 19 Nov 2021 Direct

Insider Reports Filed by Melissa Layman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FLXN Flexion Therapeutics Inc 19 Nov 2021 3 -$883,626 4 Chief Commercial Officer 19 Nov 2021, 09:03